Page last updated: 2024-11-02

oxyphenbutazone and Fibromyalgia

oxyphenbutazone has been researched along with Fibromyalgia in 4 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Fibromyalgia: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CASTAGNA, AN2
Sperling, IL1
Klinefelter, HF1

Other Studies

4 other studies available for oxyphenbutazone and Fibromyalgia

ArticleYear
[CONTRIBUTION TO THE STUDY OF INFLAMMATORY DISEASES OF THE LOCOMOTOR APPARATUS].
    La Semana medica, 1964, Apr-23, Volume: 124

    Topics: Antidepressive Agents; Arthritis; Arthritis, Rheumatoid; Drug Therapy; Fibromyalgia; Humans; Opipram

1964
[CONTRIBUTION TO THE STUDY OF THE INFLAMMATORY DISEASES OF THE LOCOMOTOR SYSTEM].
    Revista medica de Chile, 1964, Volume: 92

    Topics: Arthritis; Drug Therapy; Fibromyalgia; Humans; Oxyphenbutazone

1964
Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone.
    Lancet (London, England), 1969, Sep-06, Volume: 2, Issue:7619

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Child; Digestive System; Edema; Female; Fibromyalgia

1969
Primary fibrositis and its treatment with the pyrazolone derivatives, butazolidin and tandearil.
    The Johns Hopkins medical journal, 1972, Volume: 130, Issue:5

    Topics: Adult; Age Factors; Diagnosis, Differential; Drug Eruptions; Edema; Female; Fibromyalgia; Humans; Ma

1972